Tomonori Sekizaki

1PUBLICATIONS
7CO-AUTHORS
Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

Sort by Publication Date:
|May 17, 2021
Dipeptidyl peptidase-4 inhibitor might exacerbate Graves' disease: A multicenter observational case-control study.

Tomonori Sekizaki, Hiraku Kameda, Hiroshi Nomoto

Pageof 1

Frequent Collaborators

1 joint publications

Hiraku Kameda

1 joint publications

Hiroshi Nomoto

1 joint publications

Kyu Yong Cho

1 joint publications

Akinobu Nakamura

1 joint publications

Kiyohiko Takahashi

1 joint publications

Arina Miyoshi

1 joint publications

Hideaki Miyoshi

Frequent Collaborators

1 joint publications

Hiraku Kameda

1 joint publications

Hiroshi Nomoto

1 joint publications

Kyu Yong Cho

1 joint publications

Akinobu Nakamura

JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us

Top Related Videos

Dioscin Mediated IgA Nephropathy Alleviation by Inhibiting B Cell Activation <em>In Vivo</em> and Decreasing Galactose-Deficient IgA1 Production <em>In Vitro</em>
14:18

Dioscin Mediated IgA Nephropathy Alleviation by Inhibiting B Cell Activation <em>In Vivo</em> and Decreasing Galactose-Deficient IgA1 Production <em>In Vitro</em>

Published on : Oct 13, 2023

2.0K
See more related videos

Top Related Videos

Dioscin Mediated IgA Nephropathy Alleviation by Inhibiting B Cell Activation <em>In Vivo</em> and Decreasing Galactose-Deficient IgA1 Production <em>In Vitro</em>
14:18

Dioscin Mediated IgA Nephropathy Alleviation by Inhibiting B Cell Activation <em>In Vivo</em> and Decreasing Galactose-Deficient IgA1 Production <em>In Vitro</em>

Published on : Oct 13, 2023

2.0K
See more related videos